nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

Overview of attention for article published in Frontiers in oncology, February 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 6 X posts from 3 X users, with an upper bound of 8,404 followers.

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+) ... https://t.co/dgFo9ziUck

RT @filimasini: nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+) .…

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+) ... https://t.co/dgFo9ziUck

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+) ... https://t.co/dgFo9ziUck

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.